Multiple Myeloma Clinical Trials in Nashville

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
2021-10-14
Oct 14, 2021
C
Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
2021-10-04
Oct 4, 2021
C
Recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
2021-10-07
Oct 7, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +56 more
2021-10-07
Oct 7, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +27 more
2021-10-07
Oct 7, 2021
A
Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +19 more
2021-10-06
Oct 6, 2021
P
Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
2021-10-06
Oct 6, 2021
C
Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
2021-10-04
Oct 4, 2021
F
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Minneapolis, Minnesota
  • +6 more
2021-10-04
Oct 4, 2021
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2021-09-30
Sep 30, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +8 more
2021-09-22
Sep 22, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • KRdD followed by auto-HCT
  • KRdD only
  • Birmingham, Alabama
  • +3 more
2021-09-20
Sep 20, 2021
J
Not yet recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +30 more
2021-09-10
Sep 10, 2021
C
Recruiting
  • Multiple Myeloma
  • BB2121
  • +5 more
  • Birmingham, Alabama
  • +23 more
2021-09-14
Sep 14, 2021